ADAMTS18 and clear cell renal carcinoma: In the sunitinib-resistant clear cell renal cell carcinoma (ccRCC) cell model, ADAMTS18 was shown to down-regulate the expression levels of NCOA4, FTH1, and p53, and induced ferritin deposition to inhibit proliferation (26).